MacroGenics Inc

MGNX

NASDAQ

Biotechnology

$4.22

USD

+0.14 (+3.43%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $259.34M

Volume 851.4K

Overview Charts Financials Peers Filings & News Analyst Ratings Technical Analysis

Peer Comparison Table

(1/4)
	TRDA	Entrada Therapeutics Inc	$270.61M	-	-94.1%	-
	RNAC	Cartesian Therapeutics Inc	$262.01M	-	-94.9%	-
	MGNX	MacroGenics Inc	$256.80M	-	+2.0%	-
	RCEL	AVITA Medical Inc	$253.60M	-	+1.0%	-
	AKBA	Akebia Therapeutics Inc	$252.14M	-	+7.5%	-
	ORGO	Organogenesis Holdings Inc	$238.69M	87.79	+12.2%	-
	CAPR	Capricor Therapeutics Inc	$223.54M	-	-	-

Top Peer by Growth

Akebia Therapeutics Inc

+7.5% YoY Revenue

Best 1-Year Return

MacroGenics Inc

+145.8% Return